A detailed history of Tema Etfs LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Tema Etfs LLC holds 8,557 shares of IONS stock, worth $612,253. This represents 0.05% of its overall portfolio holdings.

Number of Shares
8,557
Previous 12,306 30.46%
Holding current value
$612,253
Previous $805 Million 15.91%
% of portfolio
0.05%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 16, 2026

SELL
$65.8 - $74.68 $246,684 - $279,975
-3,749 Reduced 30.46%
8,557 $677 Million
Q3 2025

Oct 24, 2025

SELL
$39.94 - $65.42 $633,248 - $1.04 Million
-15,855 Reduced 56.3%
12,306 $805 Million
Q2 2025

Aug 13, 2025

BUY
$25.51 - $40.0 $77,040 - $120,800
3,020 Added 12.01%
28,161 $1.11 Billion
Q1 2025

May 14, 2025

SELL
$30.17 - $34.97 $956,479 - $1.11 Million
-31,703 Reduced 55.77%
25,141 $759 Million
Q4 2024

Feb 14, 2025

BUY
$33.73 - $40.36 $1.92 Million - $2.29 Million
56,844 New
56,844 $1.99 Billion

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $10.2B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Tema Etfs LLC Portfolio

Follow Tema Etfs LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tema Etfs LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tema Etfs LLC with notifications on news.